Dobson C L, Warren A J, Pannell R, Forster A, Rabbitts T H
MRC Laboratory of Molecular Biology, Division of Protein and Nucleic Acid Chemistry, Hills Road, Cambridge CB2 2QH, UK.
EMBO J. 2000 Mar 1;19(5):843-51. doi: 10.1093/emboj/19.5.843.
Many different chromosomal translocations occur in man at chromosome 11q23 in acute leukaemias. Molecular analyses revealed that the MLL gene (also called ALL-1, HRX or HTRX) is broken by the translocations, causing fusion with genes from other chromosomes. The diversity of MLL fusion partners poses a dilemma about the function of the fusion proteins in tumour development. The consequence of MLL truncation and fusion has been analysed by joining exon 8 of Mll with the bacterial lacZ gene using homologous recombination in mouse embryonic stem cells. We show that this fusion is sufficient to cause embryonic stem cell-derived acute leukaemias in chimeric mice, and these tumours occur with long latency compared with those found in MLL-Af9 chimeric mice. These findings indicate that an MLL fusion protein can contribute to tumorigenesis, even if the fusion partner has no known pathogenic role. Thus, truncation and fusion of MLL can be sufficient for tumorigenesis, regardless of the fusion partner.
在人类急性白血病中,11号染色体长臂23区(11q23)会发生许多不同的染色体易位。分子分析显示,混合系白血病基因(MLL,也称为ALL-1、HRX或HTRX)会因这些易位而断裂,导致与其他染色体的基因发生融合。MLL融合伙伴的多样性给融合蛋白在肿瘤发生中的功能带来了难题。通过在小鼠胚胎干细胞中利用同源重组将Mll的第8外显子与细菌β-半乳糖苷酶基因连接,分析了MLL截断和融合的后果。我们发现这种融合足以在嵌合小鼠中引发源自胚胎干细胞的急性白血病,并且与MLL-Af9嵌合小鼠中发现的肿瘤相比,这些肿瘤的发生潜伏期更长。这些发现表明,即使融合伙伴没有已知的致病作用,MLL融合蛋白也可促进肿瘤发生。因此,无论融合伙伴如何,MLL的截断和融合都足以引发肿瘤发生。